Trials / Completed
CompletedNCT04812977
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion
Comparison of Intravitreal Bevacizumab and Triamcinolone Acetonide With Intravitreal Bevacizumab Alone in Macular Edema Secondary to Central Retinal Vein Occlusion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hayatabad Medical Complex · Other Government
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effect of intravitreal-Bevacizumab and Triamcinolone with intravitreal-Bevacizumab alone on visual acuity and central foveal thickness in patients with macular edema secondary to central retinal vein occlusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Group A | Combination of intravitreal triamcinolone acetonide (Kenacort-AⓇ) (2mg/0.05ml) and intravitreal bevacizumab (Avastin®) (1.25mg/0.05ml) |
Timeline
- Start date
- 2018-06-10
- Primary completion
- 2018-12-10
- Completion
- 2018-12-10
- First posted
- 2021-03-24
- Last updated
- 2022-10-03
- Results posted
- 2022-10-03
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04812977. Inclusion in this directory is not an endorsement.